Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
VNME
STRONG SELLREMOVEVendome Acquisition Corporation I · Financial Services · United States · $255M · Avg Vol: $125K/d
A micro-cap acquisition shell with no operating business, failing both the Terry Smith quality filter and the Peter Lynch growth criteria.
COMPANY DESCRIPTION
Vendome Acquisition Corporation I is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Its market position and future value are entirely dependent on the successful identification and acquisition of a high-growth private target company. As a blank check company, it offers investors exposure to potential future M&A opportunities.
FINANCIAL SUMMARY (USD)
| Year | 2025 |
|---|---|
| Revenue | — |
| EPS | — |
| Shares | 25M |
| Debt | 169,138 |
| Equity | 204M |
| Op CF | — |
| Inv CF | — |
| Fin CF | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of VNME are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| VNME | Vendome Acquisition Corporation I(you) | $255M | 13 | STRONG SELL |
| OACC | Oaktree Acquisition Corp. III Life Sciences | $263M | 13 | STRONG SELL |
| PLMK | Plum Acquisition Corp. IV | $258M | 14 | STRONG SELL |
| DMAA | Drugs Made In America Acquisition Corp. | $257M | 15 | STRONG SELL |
| MACI | Melar Acquisition Corp. I | $234M | 13 | STRONG SELL |
| RAAQ | Real Asset Acquisition Corp. | $262M | 15 | STRONG SELL |
| DYNC | Dynamix Corporation | $239M | 12 | STRONG SELL |
| TDAC | Translational Development Acquisition Corp. | $236M | 14 | STRONG SELL |
| DAAQ | Digital Asset Acquisition Corp. | $237M | 15 | STRONG SELL |
| HVII | Hennessy Capital Investment Corp. VII | $271M | 11 | STRONG SELL |
Peer medians: ROE 10.8% · P/E 13.6x · Gross margin 0.0%